Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence
- 1 March 2008
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 108 (3) , 525-532
Abstract
Object: Nonfunctioning pituitary adenomas (NFPAs) are benign tumors of the pituitary gland that typically cause visual and/or hormonal dysfunction. Surgery is the treatment of choice, but patients remain at risk for tumor recurrence for several years afterwards. The authors evaluate the early results of surgery and the long-term risk of tumor recurrence in patients with NFPAs. Methods: Between 1990 and 2005, 491 previously untreated patients with NFPA underwent surgery at the Università Vita-Salute. Determinations of recurrence or growth of the residual tumor tissue during the follow-up period were based on neuroradiological criteria. Results: Residual tumor after surgery was detected in 173 patients (36.4%). Multivariate analysis showed that invasion of the cavernous sinus, maximum tumor diameter, and absence of tumor apoplexy were associated with an unfavorable surgical outcome. At least 2 sets of follow-up neuroimaging studies were obtained in 436 patients (median follow-up 53 months). Tumors recurred in 83 patients (19.0%). When tumor removal appeared complete, younger age at surgery was associated with a risk of tumor recurrence. In patients with incomplete tumor removal, adjunctive postoperative radiotherapy had a marked protective effect against growth of residual tumor. Conclusions: Complete surgical removal of NFPAs can be safely achieved in > 50% of cases. Visual symptoms and, less frequently, pituitary function may improve after surgery. However, tumor can recur in patients after apparently complete surgical removal. In patients with incomplete tumor removal, radiation therapy is the most effective adjuvant therapy for preventing residual tumor growth.Keywords
This publication has 47 references indexed in Scilit:
- Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulkingJournal of Neurosurgery, 2004
- Clinically Silent Corticotroph Tumors of the Pituitary GlandNeurosurgery, 2000
- Determination of the Proliferation and Apoptotic Index in Adrenocorticotropin-Secreting Pituitary TumorsThe American Journal of Pathology, 2000
- Recovery of Hypopituitarism after Neurosurgical Treatment of Pituitary AdenomasThe Journal of Clinical Endocrinology & Metabolism, 1999
- Radiotherapy for non‐functioning pituitary tumoursClinical Endocrinology, 1998
- Pituitary Adenomas with Invasion of the Cavernous Sinus SpaceNeurosurgery, 1993
- FACTORS IN THE OUTCOME OF TRANSSPHENOIDAL SURGERY FOR PROLACTINOMA AND NON‐FUNCTIONING PITUITARY TUMOUR, INCLUDING PREOPERATIVE BROMOCRIPTINE THERAPYClinical Endocrinology, 1987
- Hormone production in clinically nonfunctioning pituitary adenomasJournal of Neurosurgery, 1987
- Recurrence of chromophobe pituitary adenomas after operation and postoperative radiotherapyActa Neurologica Scandinavica, 1982
- Transsphenoidal microsurgical removal of 250 pituitary adenomasJournal of Neurosurgery, 1978